Please use a minimum of three unique search words
Our search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Trulicity ® (dulaglutide)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Can Trulicity® (dulaglutide) be used in patients with COVID-19?
Lilly has not studied the use of dulaglutide in patients with COVID-19 nor in patients at risk of contracting COVID-19.
Can dulaglutide be used in patients with respiratory infections?
According to the dulaglutide label, respiratory infections
- are not listed as a warning or precautions for use of dulaglutide, and
- are not listed as adverse events.1
Use your clinical judgment to choose the most appropriate approach to treat Type 2 Diabetes patients with confirmed or suspected COVID-19.
Infectious Disease Resources for COVID-19
For current information on COVID-19, please refer to
- Coronavirus disease (COVID-19) outbreak on the website of the European regional office of the World Health Organization (EU WHO)
- Coronavirus disease (COVID-19) outbreak: guidance for people with diabetes on the website of the International Diabetes Federation (IDF), and
- COVID-19 on the website of the European Centre for Disease Prevention and Control (ECDC).2-4
1Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
2Coronavirus disease (COVID-19) outbreak. European web page of the World Health Organization. Accessed March 20, 2020. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19
3International Diabetes Federation Europe. COVID-19 outbreak: guidance for people with diabetes. https://www.idf.org/our-network/regions-members/europe/europe-news/196-information-on-corona-virus-disease-2019-covid-19-outbreak-and-guidance-for-people-with-diabetes.html. Accessed March 18, 2020
4COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china
Date of Last Review: 16 March 2020